Management anticipates high-single to low-double digit growth in both loans and deposits for Q2 2025, leveraging Florida's strong economic growth. The loan pipeline remains robust and diversified, ...

Erasca continues developing novel RAS-pathway cancer drugs, backed by funding through 2027 and promising early results. Find ...